Whitlockite nanoparticles for inducing bone regeneration
Whitlockite nanoparticles for inducing bone regeneration
批准号:
9187371
负责人:
Ali Khademhosseini
金额:
$19.53万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-07-01 至 2018-06-30
关键词:
3D PrintArchitectureBiocompatible MaterialsBiologicalBiomimeticsBlood VesselsBone DiseasesBone RegenerationBone TissueBone TransplantationCell ProliferationCellsCeramicsChemicalsCommunitiesCompartment syndromesDepositionEncapsulatedEngineeringEsthesiaFractureGelGoalsHealedHigh temperature of physical objectHomeostasisHybridsHydrogelsHydroxyapatitesImplantInfectionInkIonsMechanicsMesenchymal Stem CellsMethodsMineralsMorphologyNatural regenerationNerveOperative Surgical ProceduresOsteogenesisPainPatientsPhasePhysically HandicappedPorosityPrintingProcessPropertyPublic HealthReportingResearchSolubilityStagingStructureTissuesTransplanted tissueUnited StatesVascularizationabstractingagedbasebiomaterial compatibilitybonecell injurychemical propertychronic paincostdesigndisabilityeffective therapyhealingimplant materialimplantationin vivoinnovationmimeticsmouse modelnanocompositenanoparticlenanoscalenovelosteogenicparticlerepairedscaffoldsocioeconomicsstem cell differentiationtherapy developmenttissue regenerationtricalcium phosphateuptake
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
Nonunion fracture is a permanently broken bone that does not spontaneously heal and can occur in any bone
tissue, causing severe pain and physical disability to patient. However, until now, there is no effective
treatment for nonunion fracture and its pathological mechanism remains unidentified. To treat nonunion
fracture, bone graft materials are often implanted into the damaged region to stimulate bone regeneration and
to support bone structure. Among various bone implant materials, hydroxyapatite (HAP: Ca10(PO4)6(OH)2) and
β-tricalcium phosphate (β-TCP: Ca3(PO4)2) are the most widely used biomaterials due to excellent
biocompatibility and bioresorbability, respectively. However, β-TCP does not exist in our bone while it has
microscale particle. In this respect, the current bone implant material, composed of HAP and β-TCP, does not
reflect composition and structure of bone at nanoscale and thus has a gap with natural bone tissue, that it is
eventually purposed to be replaced by new bone. Therefore, to make a breakthrough in bone implant material,
we propose to recreate an innovative bone implant material which can immediately harmonize with
surrounding bone tissue after implantation, by utilizing the two major bone minerals, whitlockite (WH:
Ca18Mg2(HPO4)2(PO4)12) and HAP. WH is the second most abundant crystal in bone and also known to exist
with high ratio in younger aged and early stage of bone tissue formation. However, despite its significant
distributions in bone, WH has been largely ignored from the research fields due to difficulty in its synthesis and
analyses. Very recently, a facile synthetic method of WH nanoparticles has been reported and its beneficial
effects on cellular proliferation and activities has been demonstrated. In this research, we aim to recreate
bone-mimetic implant platform by controlling and optimizing the composition and the structure of the two major
bone minerals in 3D hydrogel platform. We hypothesized that the two-phase WH/HAP composite will provide
synergetic effects of material-, mechanical-, and biological properties on cellular proliferation and differentiation.
This hypothesis will be verified by the following specific aims: 1) Assess the differentiation of MSCs into
osteogenic cells in nanocomposite gels containing various ratios of WH and HAP nanoparticles; 2) Control the
spatial architecture of MSC-laden WH/HAP nanocomposite gels by 3D printing; and 3) Assess the bone
formation ability of WH/HAP nanocomposite gels in vivo. We expect that the new findings from the proposed
research will provide better understandings of bone tissue and effective treatment for nonunion fractures.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Drug eluting injectable biomaterials for next generation chemoembolization
-
批准号:10397659
-
项目类别:
-
资助金额:$65.04万
-
财政年份:2021
-
负责人:Ali Khademhosseini
-
依托单位:
Healing enterocutaneous fistulas using bioengineered biomaterials
-
批准号:10384769
-
项目类别:
-
资助金额:$59.16万
-
财政年份:2021
-
负责人:Ali Khademhosseini
-
依托单位:
Drug eluting injectable biomaterials for next generation chemoembolization
-
批准号:10620134
-
项目类别:
-
资助金额:$63.79万
-
财政年份:2021
-
负责人:Ali Khademhosseini
-
依托单位:
Drug eluting injectable biomaterials for next generation chemoembolization
-
批准号:10230909
-
项目类别:
-
资助金额:$68.02万
-
财政年份:2021
-
负责人:Ali Khademhosseini
-
依托单位:
Healing enterocutaneous fistulas using bioengineered biomaterials
-
批准号:10532787
-
项目类别:
-
资助金额:$57.29万
-
财政年份:2021
-
负责人:Ali Khademhosseini
-
依托单位:
Treatment of arterial aneurysms using an injectable biomaterial
-
批准号:10171610
-
项目类别:
-
资助金额:$60.75万
-
财政年份:2018
-
负责人:Ali Khademhosseini
-
依托单位:
Treatment of arterial aneurysms using an injectable biomaterial
-
批准号:9883832
-
项目类别:
-
资助金额:$63.67万
-
财政年份:2018
-
负责人:Ali Khademhosseini
-
依托单位:
Engineering personalized micro-tumor ecosystems
-
批准号:10261573
-
项目类别:
-
资助金额:$61.49万
-
财政年份:2017
-
负责人:Ali Khademhosseini
-
依托单位:
Engineering personalized micro-tumor ecosystems
-
批准号:9756346
-
项目类别:
-
资助金额:$77.55万
-
财政年份:2017
-
负责人:Ali Khademhosseini
-
依托单位:
Targeted chemotherapy delivery and capture
-
批准号:9913518
-
项目类别:
-
资助金额:$53.84万
-
财政年份:2017
-
负责人:Ali Khademhosseini
-
依托单位:
Targeted chemotherapy delivery and capture
-
批准号:9333647
-
项目类别:
-
资助金额:$55.29万
-
财政年份:2017
-
负责人:Ali Khademhosseini
-
依托单位:
Engineering personalized micro-tumor ecosystems
-
批准号:9981696
-
项目类别:
-
资助金额:$74.21万
-
财政年份:2017
-
负责人:Ali Khademhosseini
-
依托单位:
Smart wound dressing for treating chronic diabetic ulcers
-
批准号:9124291
-
项目类别:
-
资助金额:$26.63万
-
财政年份:2016
-
负责人:Ali Khademhosseini
-
依托单位:
Catheter guided endovascular electric field ablation for thrombosis therapy.
-
批准号:9055536
-
项目类别:
-
资助金额:$22.98万
-
财政年份:2016
-
负责人:Ali Khademhosseini
-
依托单位:
Smart wound dressing for treating chronic diabetic ulcers
-
批准号:9221335
-
项目类别:
-
资助金额:$21.82万
-
财政年份:2016
-
负责人:Ali Khademhosseini
-
依托单位:
A miniaturized model of human skin and lymph node for drug discovery and testing
-
批准号:8915940
-
项目类别:
-
资助金额:$44.24万
-
财政年份:2014
-
负责人:Ali Khademhosseini
-
依托单位:
3D combinatorial microenvironments for effective cell based therapy
-
批准号:8000572
-
项目类别:
-
资助金额:$63.78万
-
财政年份:2010
-
负责人:Ali Khademhosseini
-
依托单位:
3D combinatorial microenvironments for effective cell based therapy
-
批准号:8281574
-
项目类别:
-
资助金额:$67.82万
-
财政年份:2010
-
负责人:Ali Khademhosseini
-
依托单位:
3D combinatorial microenvironments for effective cell based therapy
-
批准号:8464773
-
项目类别:
-
资助金额:$67.86万
-
财政年份:2010
-
负责人:Ali Khademhosseini
-
依托单位:
3D combinatorial microenvironments for effective cell based therapy
-
批准号:8111958
-
项目类别:
-
资助金额:$63.14万
-
财政年份:2010
-
负责人:Ali Khademhosseini
-
依托单位:
海外基金